Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
My69z's Profile
Displaying 201-250 of 1327 result(s).
CYDY CytoDyn Inc
06/24/2025 3:28:00 PM
" The groups are discussing orderi (1)
CYDY CytoDyn Inc
06/22/2025 1:47:51 AM
Hiv resevoir new grant: 6/1/25 *Thu (6)
CYDY CytoDyn Inc
06/20/2025 6:05:19 PM
It was a measurement in a trial the (1)
CYDY CytoDyn Inc
06/20/2025 7:08:49 AM
Could add -- PD-L1 was a Outcome Me (2)
CYDY CytoDyn Inc
06/19/2025 8:27:26 PM
Weeks ago FDA said chainging the cl (3)
CYDY CytoDyn Inc
06/19/2025 8:19:17 PM
Gilead -- 2 drugs: Tuesday, April 2 (7)
CYDY CytoDyn Inc
06/18/2025 9:56:03 PM
Canonical immune checkpoint respons (4)
CYDY CytoDyn Inc
06/17/2025 8:45:56 AM
Pretending. LMAO. None of this addr (1)
CYDY CytoDyn Inc
06/16/2025 1:19:17 PM
If we do a market raise, before rel (9)
CYDY CytoDyn Inc
06/16/2025 8:27:48 AM
Yea, i don't understand why this wa (5)
CYDY CytoDyn Inc
06/16/2025 3:17:44 AM
So a generalized 9 companies ? ---
CYDY CytoDyn Inc
06/15/2025 10:50:08 PM
Woops...40% are brain tumors
CYDY CytoDyn Inc
06/15/2025 10:19:10 PM
Several PD-1 inhibitors are approve (2)
CYDY CytoDyn Inc
06/15/2025 9:30:19 PM
Pembrolizumab (KEYTRUDA) is the onl (4)
CYDY CytoDyn Inc
06/15/2025 7:38:10 PM
Cornell IRB schedule: For the 2024- (5)
CYDY CytoDyn Inc
06/15/2025 4:37:24 PM
misiu, Ken & Kat....thx for all the (5)
CYDY CytoDyn Inc
06/15/2025 1:05:49 AM
Rukobia (fostemsavir) is manufactur (3)
CYDY CytoDyn Inc
06/15/2025 12:49:55 AM
Top Drugs To Watch in HIV (2025): T (4)
CYDY CytoDyn Inc
06/14/2025 10:29:55 AM
These studies started years ago. Ye (2)
CYDY CytoDyn Inc
06/14/2025 9:19:03 AM
Side effects reasoning ? & if so, t (1)
CYDY CytoDyn Inc
06/14/2025 8:48:37 AM
Ugh...here's link again https://rep (2)
CYDY CytoDyn Inc
06/14/2025 8:39:20 AM
Dr. Sacha Project End Date 30-June- (9)
CYDY CytoDyn Inc
06/13/2025 2:56:02 PM
dfwl -- 2022 DOD slipped them $1m f (4)
CYDY CytoDyn Inc
06/12/2025 11:30:19 PM
Few weeks ago i said if eventually (3)
CYDY CytoDyn Inc
06/12/2025 10:45:25 PM
Sounds like Richard Pazdur, head of (4)
CYDY CytoDyn Inc
06/12/2025 10:01:11 PM
chazzle --Cytodyn qualified & shoul (7)
CYDY CytoDyn Inc
06/12/2025 9:20:44 PM
Suggest reading Vinay Prasad from y (5)
CYDY CytoDyn Inc
06/12/2025 8:45:33 PM
Looking for a roster --- no luck ye (4)
CYDY CytoDyn Inc
06/12/2025 8:16:10 PM
FDA Commissioner Dr. Martin A. Maka (4)
CYDY CytoDyn Inc
06/12/2025 12:47:28 PM
Then i guess Max is @ the SE Front. (1)
CYDY CytoDyn Inc
06/12/2025 12:38:00 PM
"something in a few days"....if no
CYDY CytoDyn Inc
06/12/2025 11:11:49 AM
100% facts. & using 88% instead of
CYDY CytoDyn Inc
06/11/2025 1:06:38 PM
Cleaning up the optics to a partner (5)
CYDY CytoDyn Inc
06/10/2025 7:29:13 PM
US Patent Office could for sure Ai
CYDY CytoDyn Inc
06/10/2025 6:09:50 PM
Yes sir -- & ESMO was pooled from t (3)
CYDY CytoDyn Inc
06/10/2025 6:01:06 PM
The FDA's review process for BTD re (2)
CYDY CytoDyn Inc
06/10/2025 5:47:06 PM
NCT04313075: This is a single arm, (3)
CYDY CytoDyn Inc
06/10/2025 9:09:13 AM
Remember it was multiple countries
CYDY CytoDyn Inc
06/10/2025 8:54:20 AM
Being the data was not corrupted pe (1)
CYDY CytoDyn Inc
06/10/2025 8:51:26 AM
KC --- i looked @ that news trials, (2)
CYDY CytoDyn Inc
06/10/2025 8:09:24 AM
Agree --- prostate too comes 2 mind (1)
CYDY CytoDyn Inc
06/10/2025 8:07:32 AM
KC, ... 3 pooled trials, 90 patient (4)
CYDY CytoDyn Inc
06/10/2025 4:00:01 AM
Sorry ....dam links ---copy this if (3)
CYDY CytoDyn Inc
06/10/2025 1:55:54 AM
No BTD application in history has e (2)
CYDY CytoDyn Inc
06/10/2025 1:45:17 AM
March 2025 Update The Company conti (2)
CYDY CytoDyn Inc
06/10/2025 12:40:53 AM
If you put 9 of the 21 brain mets a (1)
CYDY CytoDyn Inc
06/10/2025 12:17:21 AM
Past BTD application -- WOW !! All (4)
CYDY CytoDyn Inc
06/08/2025 5:54:13 PM
The global chemotherapy market was (7)
CYDY CytoDyn Inc
06/08/2025 5:08:44 PM
*PARP helps repair DNA when it beco (4)
CYDY CytoDyn Inc
06/08/2025 2:56:12 PM
Think 5 "MOA Synergies". Far beyond (2)
Go to page:
  • << First
  • < Previous
  • 4
  • 5
  • Next >

Recent Articles

  • Merus to Join Forces with Genmab in Groundbreaking $8B Acquisition
  • Nordic Fibreboard Completes Successful Share Offering
  • Valeura Energy Achieves Top Spot Among Canada's Growing Companies
  • Discover the HUAWEI WATCH GT 6: Customizable Fitness Revolution
  • Loomis Completes Significant Share Repurchase Initiative
  • Affordable Investor Fee Updates for 21Shares Exchange Traded Products
  • 21Shares Expands Crypto ETP Lineup with Jupiter Launch
  • Harnessing Sustainability in Housing: Insights from SATO
  • Effective Strategies for Lower-Cost Bitcoin and Ethereum Access
  • Advantest's Innovative Power Solution Boosts Sustainability in Testing
  • Exploring the New Gaza Peace Initiative Proposed by Trump
  • Marjorie Taylor Greene's Investment Strategy: Treasury Bills and Stocks
  • Nike Prepares for Q1 Earnings Report: Analyst Insights
  • iGarden's Innovative Partnership at World Rowing Championships
  • Market Rebounds: Tech Stocks Surge Despite Mixed Sentiment
  • Bank of America's AI Innovations in Global Payments Solutions
  • Tesla's FSD Breakthrough: 621,000 Miles Driven in Two Weeks
  • Edgen Transforms Market Analysis with Multi-Agent Intelligence
  • CaPow Achieves CE Mark for Innovative Genesis System
  • Strengthening Youth Mental Health through School Psychologists
  • Symphony Talent Shines at the 2025 Employer Brand Awards
  • Comprehensive Insights on the New US Pallet Pricing Service
  • Outstanding Achievements for Symphony Talent in Employer Branding
  • Empowering Industrial Workers Through Innovative Education Programs
  • GAC Expands European Electric Vehicle Reach with AION V
  • CLO Summit 2025: A Hub for 3D Fashion Collaboration
  • Capgemini Partners with Six Nations Rugby to Elevate Fan Experience
  • INVL Private Equity Fund II Acquires Major Stake in EKT
  • Key Market Movers: Paychex, Progress Software and More
  • Understanding Sobi's Latest Share Adjustments and Growth
  • Natus Medical's Acquisition of Holberg EEG Promises AI Revolution in Healthcare
  • Wynn Macau Launches Exquisite Hypercar Exhibition Experience
  • Autoliv Retires Shares and Adjusts Issued Share Count
  • Unveiling EpiFinder™ GenomePro: A Leap in Epigenomic Research
  • VINCI Secures Major Highway Contract Worth €120 Million
  • Strategic Acquisition to Transform Falcon Oil & Gas Ltd.
  • Tamboran and Falcon Oil & Gas Join Forces for Beetaloo Basin Expansion
  • Ericsson Announces Third Quarter 2025 Media Briefing Details
  • Ericsson Gears Up for Q3 2025 Financial Briefing Event
  • Måna's Digital Caregiving Assistant Expands Independent Living
  • Join Ericsson's Engaging Q3 2025 Reporting Event
  • Sivers Semiconductors Reports Significant Increase in Shares
  • Måna Revolutionizes Elderly Care with New Digital Platform
  • Sobi Shares and Voting Rights: Latest Updates You Should Know
  • Autoliv Reduces Issued Shares Through Strategic Buybacks
  • Antenna Market Growth Driven by Innovations and Defense Needs
  • Instant Payments Set for Massive Growth Beyond $110 Trillion
  • T420 Launches Innovative Robotaxi Network on Solana Blockchain
  • Civinity Group Sees Revenue and Profit Surge in 2025
  • Ageas Acquires esure: A Landmark Move in UK Insurance Market
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site